Clinical Trial Update: A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the short-term safety of continuous dosing of abiraterone acetate with prednisone under modified fasting and fed states in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Prostate Neoplasms, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-30